GMED240816C85000
- 0.15
- 0.000.00%
Globus Medical Newsroom
Globus Medical: A Balanced Hold Rating Amid Growth and Integration Risks
What 8 Analyst Ratings Have To Say About Globus Medical
Globus Medical Is Maintained at Outperform by RBC Capital
Express News | Globus Medical Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results
Earnings Call: Globus Medical Sees Strong Q2 Growth, Bullish on Outlook
Globus Medical (GMED) Q2 Earnings Top Estimates, '24 View Up
Express News | Truist Securities Maintains Hold on Globus Medical, Raises Price Target to $79
Globus Medical Price Target Raised to $78.00/Share From $60.00 by Wells Fargo
Wells Fargo Upgrades Globus Medical to Overweight From Equalweight, Adjusts Price Target to $78 From $60
Needham Reaffirms Their Hold Rating on Globus Medical (GMED)
Buy Rating Justified for Globus Medical on Strong Performance and Strategic Positioning
Express News | Needham Reiterates Hold on Globus Medical
Globus Medical Analyst Ratings
Express News | Globus Medical Inc : Jefferies Raises Target Price to $85 From $78
Globus Medical, Inc. (GMED) Q2 2024 Earnings Call Transcript
Globus Medical | 10-Q: Q2 2024 Earnings Report
Express News | Corrected-Globus Medical Inc Sees FY Revenue $2.47 Bln to $2.49 Bln (Adds Dropped Currency '$')
Express News | Globus Medical Inc Sees FY Adj EPS $2.80 to $2.90
Express News | Globus Medical Inc Sees FY Revenue 2.47 to $2.49 Bln
Express News | Globus Medical Sees FY24 Adj. EPS $2.80-$2.90 Vs $2.82 Est.; Revenue $2.47B-$2.49B Vs $2.475B Est